T8	Exp 86 116	the tissue-specific expression
T9	Exp 256 279	the transcription start
T10	Exp 314 337	the positive activities
T11	Exp 341 365	the AP-1 and Elf-1 sites
T12	Exp 369 386	the IL-3 promoter
T13	Exp 621 626	which
T14	Exp 388 404	The contribution
T15	Exp 585 619	the core binding factor (CBF) site
T16	Exp 686 698	the CBF site
T17	Exp 738 771	the adjacent activator site Act-1
T18	Exp 782 805	the Act-1 and CBF sites
T19	Exp 926 930	both
T20	Exp 859 870	The AC unit
T21	Exp 959 972	This activity
T22	Exp 1150 1154	that
T23	Exp 1055 1091	the already identified NIP repressor
T24	Exp 1314 1318	that
T25	Exp 1263 1280	the IL-3 promoter
T26	Exp 1396 1400	that
T27	Exp 1548 1552	that
T28	Exp 1447 1459	the activity
T29	Exp 1370 1383	these results
R4	Coref Anaphora:T13 Antecedent:T15
R5	Coref Anaphora:T22 Antecedent:T30
R6	Coref Anaphora:T27 Antecedent:T31
T1	Protein 120 133	interleukin-3
T2	Protein 166 179	interleukin-3
T3	Protein 181 185	IL-3
T4	Protein 373 377	IL-3
T5	Protein 509 513	IL-3
T6	Protein 1267 1271	IL-3
T7	Protein 1422 1426	IL-3
T30	Exp 1124 1149	a second repressor region
T31	Exp 1518 1547	multiple interacting elements
